


FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%

FDA Approves IVIG to Treat Adults with Dermatomyositis
Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults

Case Report: Rapidly Progressive Interstitial Lung Disease in a 6-Year-Old

Myositis-Specific Antibodies Identified

Cancer-Associated Myositis: A Case Report & Review of the Literature

Promising Avenues in Myositis: Research Targets Disease Specificity

Fellows’ Forum Case Report: Progressive Weakness and Debilitation with Skin Rash
